Skip to content
News
Data
Podcast
Clinics
EVENTS
News
Data
Podcast
Clinics
EVENTS
Search
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Advertise
NEWSLETTER
News
Data
Podcast
Clinics
EVENTS
News
Data
Podcast
Clinics
EVENTS
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
About
Contact
About
Contact
Advertise
nEWSLETTER
Search
Search
Cala launches nationwide kI...
Resolution Therapeutics to ...
Genentech, Alector partner ...
Coya Therapeutics completes...
Alterity’s Parkinson’s drug...
Cala launches nationwide kI...
Resolution Therapeutics to ...
Genentech, Alector partner ...
Coya Therapeutics completes...
Alterity’s Parkinson’s drug...
Longevity Investors Conference
Ecosystem
Investment
Investment
Longevity investors put evidence to the test
Diagnostics
Building a health system that puts prevention first
Diagnostics
Ecosystem
Features
‘Aging clocks are tools – not verdicts’
Ecosystem
Investment
Investment
Longevity capital heads to Gstaad
Ecosystem
Investment
Investment
Longevity capital pauses to think at Davos
Investment
Investment
Investing in the future of longevity
Economy
Investment
Investment
Longevity Investors Conference returns to Gstaad in September
Economy
Investment
Investment
Longevity and healthspan take center stage at Davos gathering
Economy
Investment
Investment
Longevity investors convene for global innovation and collaboration
The latest longevity science, investment, innovation and insight, delivered every morning.
First Name
(Required)
Email Address
(Required)
Contact Source
Unlock Longevity Biotech Report for FREE
$617BN - Annual global revenue by 2045
$30BN+ - Invested in under 2 years
3,036 - Therapeutics individually assessed
Access full report
